Skip to main content
. 2020 Jul 29;5(1):e000533. doi: 10.1136/tsaco-2020-000533

Table 1.

Patient demographics and clinical characteristics in β-blocker unexposed (BB−) and β-blocker exposed (BB+) patients undergoing surgery for hip fracture

BB− BB+ P value
n=1543 n=900
Age in years, mean (SD) 81.1 (10.6) 83.4 (8.3) <0.001
Sex, n (%) 0.34
 Female 1049 (68.0) 595 (66.1)
 Male 494 (32.0) 305 (33.9)
Type of β-blocker, n (%)
 Atenolol 209 (23.2)
 Bisoprolol 293 (32.6)
 Metoprolol 350 (38.9)
 Other 48 (5.3)
ASA classification, n (%) <0.001
 1 160 (10.4) 24 (2.8)
 2 709 (45.9) 292 (32.4)
 3 591 (38.3) 472 (52.4)
 4 75 (4.9) 110 (12.2)
 Missing 8 (0.5) 2 (0.2)
Charlson Comorbidity Index, n (%) <0.001
 ≤4 603 (39.1) 180 (20.0)
 5–6 584 (37.8) 338 (37.6)
 ≥7 356 (23.1) 382 (42.4)
Fracture type, n (%) 0.13
 Non-displaced cervical (Garden 1–2) 213 (13.8) 108 (12.0)
 Displaced cervical (Garden 3–4) 565 (36.6) 307 (34.1)
 Basicervical 72 (4.7) 39 (4.3)
 Pertrochanteric (two fragments) 361 (23.4) 226 (25.1)
 Pertrochanteric (multiple fragments) 237 (15.4) 142 (15.8)
 Subtrochanteric 95 (6.2) 78 (8.7)
Type of surgery, n (%) 0.22
 One screw or pin 2 (0.1) 2 (0.2)
 Two screws or pins 322 (20.9) 162 (18.0)
 Three screws or pins 2 (0.1) 1 (0.1)
 Screws or pins with side plate 546 (35.4) 336 (37.3)
 Intramedullary rod 239 (15.5) 162 (18.0)
 Hemiarthroplasty 309 (20.0) 182 (20.2)
 Total hip replacement 123 (8.0) 55 (6.1)

ASA, American Society of Anesthesiologists; SD, Standard deviation.